PL3049073T3 - Kompozycje i sposoby destabilizowania, modyfikowania i rozpraszania biofilmów - Google Patents

Kompozycje i sposoby destabilizowania, modyfikowania i rozpraszania biofilmów

Info

Publication number
PL3049073T3
PL3049073T3 PL14847319T PL14847319T PL3049073T3 PL 3049073 T3 PL3049073 T3 PL 3049073T3 PL 14847319 T PL14847319 T PL 14847319T PL 14847319 T PL14847319 T PL 14847319T PL 3049073 T3 PL3049073 T3 PL 3049073T3
Authority
PL
Poland
Prior art keywords
destabilizing
altering
compositions
dispersing biofilms
biofilms
Prior art date
Application number
PL14847319T
Other languages
English (en)
Inventor
Alexander RICKARD
Nick JAKUBOVICS
Derek S. Samarian
Ethan KOLDERMAN
Original Assignee
The Regents Of The University Of Michigan
University Of Newcastle Upon Tyne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52744423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3049073(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Regents Of The University Of Michigan, University Of Newcastle Upon Tyne filed Critical The Regents Of The University Of Michigan
Publication of PL3049073T3 publication Critical patent/PL3049073T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14Streptococcus; Staphylococcus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Plant Pathology (AREA)
  • Physiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Nutrition Science (AREA)
PL14847319T 2013-09-24 2014-09-24 Kompozycje i sposoby destabilizowania, modyfikowania i rozpraszania biofilmów PL3049073T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361881762P 2013-09-24 2013-09-24
US201461972920P 2014-03-31 2014-03-31
PCT/US2014/057235 WO2015048146A1 (en) 2013-09-24 2014-09-24 Compositions and method for destabilizing, altering, and dispersing biofilms
EP14847319.2A EP3049073B1 (en) 2013-09-24 2014-09-24 Compositions and method for destabilizing, altering, and dispersing biofilms

Publications (1)

Publication Number Publication Date
PL3049073T3 true PL3049073T3 (pl) 2021-10-25

Family

ID=52744423

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14847319T PL3049073T3 (pl) 2013-09-24 2014-09-24 Kompozycje i sposoby destabilizowania, modyfikowania i rozpraszania biofilmów

Country Status (11)

Country Link
US (2) US20160235698A1 (pl)
EP (3) EP3049073B1 (pl)
CN (3) CN110129352A (pl)
AU (5) AU2014326756B2 (pl)
BR (1) BR112016006584B1 (pl)
DK (1) DK3049073T3 (pl)
ES (1) ES2847388T3 (pl)
MX (1) MX2016003791A (pl)
PL (1) PL3049073T3 (pl)
WO (1) WO2015048146A1 (pl)
ZA (1) ZA201602797B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2463181B (en) 2007-05-14 2013-03-27 Univ New York State Res Found Induction of a physiological dispersion response in bacterial cells in a biofilm
BR112016006584B1 (pt) 2013-09-24 2022-11-29 University Of Newcastle Upon Tyne Uso de l-arginina e método para desestabilizar, alterar, e dispersar biofilmes
US9795579B1 (en) * 2017-04-24 2017-10-24 Knoze Jr. Corporation Oral microbiota promoting method
KR20200123146A (ko) * 2018-02-21 2020-10-28 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 이차 작용 방식을 갖는 새로운 항균제에 대한 조성물 및 방법
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
US10927397B2 (en) 2018-10-16 2021-02-23 Sterilex, Llc Compositions, devices and methods for detecting biofilms
CN113226258A (zh) * 2018-12-26 2021-08-06 高露洁-棕榄公司 将口腔中的生物膜从病原性生物膜转变为健康生物膜的方法
AU2019417312B2 (en) * 2018-12-26 2022-12-15 Colgate-Palmolive Company Reduction of pathogenic bacteria using arginine
MX2021007646A (es) * 2018-12-26 2021-08-11 Colgate Palmolive Co Inhibicion de la coagregacion especifica por arginina.
CN110583697B (zh) * 2019-09-20 2021-04-06 浙江工商大学 去除铜绿假单胞菌生物膜用的高效化学生物制剂及其应用
US20220395442A1 (en) * 2019-11-08 2022-12-15 Colgate-Palmolive Company Methods of Modifying Biofilm
CN111299267B (zh) * 2020-02-12 2021-10-22 上海交通大学 一种基于群感效应的供水管网生物膜控制方法及其应用
WO2023114550A2 (en) * 2021-12-19 2023-06-22 The Trustees Of Columbia University In The City Of New York Engineering bacteria swarm patterns for spatiotemporal information encoding

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0065884B1 (en) 1981-05-27 1986-08-20 Unitika Ltd. Urethral catheter capable of preventing urinary tract infection and process for producing the same
EP1159951A1 (en) * 2000-06-02 2001-12-05 Societe Des Produits Nestle S.A. Use of exogenous lactic bacteria strain against Actinomyces naeslundii-related diseases
AU4816200A (en) * 1999-05-03 2000-11-17 Advanced Research And Technology Institute, Inc. Methods and compositions for controlling dental caries, and recombinant smaa polypeptides useful for same
AU2001286741A1 (en) * 2000-08-25 2002-03-04 Trustees Of Tufts College Methods and compositions for potentiating antibiotic action against persistent/tolerant pathogenic microorganisms
US20100021942A1 (en) * 2008-07-25 2010-01-28 Paul Freemont Cell-free expression system for the detection of bacterial biofilms
WO2010075419A1 (en) * 2008-12-22 2010-07-01 Micropure, Inc Composition and method for reducing demineralization of teeth
US9579269B2 (en) * 2010-06-23 2017-02-28 Colgate-Palmolive Company Therapeutic oral composition
JP5753271B2 (ja) 2010-10-27 2015-07-22 コルゲート・パーモリブ・カンパニーColgate−Palmolive Company アルギニンおよび炭酸カルシウムを含むオーラルケア製品ならびにその使用方法および製造方法
US9717929B2 (en) * 2010-12-07 2017-08-01 Colgate-Palmolive Company Dentifrice compositions containing calcium silicate and a basic amino acid
JP6038167B2 (ja) * 2011-10-31 2016-12-07 ケーン バイオテク インコーポレーテッド 口腔疾患を予防及び治療する組成物及び方法
CN103974688A (zh) * 2011-12-15 2014-08-06 高露洁-棕榄公司 口腔护理组合物
BR112016006584B1 (pt) 2013-09-24 2022-11-29 University Of Newcastle Upon Tyne Uso de l-arginina e método para desestabilizar, alterar, e dispersar biofilmes

Also Published As

Publication number Publication date
ES2847388T3 (es) 2021-08-03
EP3049073B1 (en) 2020-11-04
BR112016006584B1 (pt) 2022-11-29
MX2016003791A (es) 2017-01-20
AU2021202650A1 (en) 2021-05-27
AU2014326756A1 (en) 2016-04-07
EP3150715A1 (en) 2017-04-05
ZA201602797B (en) 2018-12-19
EP3831374A1 (en) 2021-06-09
EP3049073A1 (en) 2016-08-03
EP3150715B1 (en) 2018-11-14
AU2016202002A1 (en) 2016-04-21
AU2019271937A1 (en) 2019-12-19
EP3049073A4 (en) 2017-03-15
US20160235698A1 (en) 2016-08-18
BR112016006584A2 (pt) 2017-08-01
CN106029062A (zh) 2016-10-12
US10570401B2 (en) 2020-02-25
CN115177607A (zh) 2022-10-14
AU2016202002B2 (en) 2017-10-12
AU2019271937B2 (en) 2021-01-28
CN110129352A (zh) 2019-08-16
WO2015048146A1 (en) 2015-04-02
AU2022271381A1 (en) 2022-12-15
US20160304886A1 (en) 2016-10-20
DK3049073T3 (da) 2021-02-01
AU2014326756B2 (en) 2019-08-29
AU2021202650B2 (en) 2022-09-08

Similar Documents

Publication Publication Date Title
ZA201602797B (en) Compositions and method for destabilizing, altering, and dispersing biofilms
EP3028691A4 (en) CERAMIDE DISPERSION COMPOSITION
GB201319525D0 (en) Composition
EP2889350A4 (en) ADHESIVE COMPOSITION
EP3071295A4 (en) Anti-infective methods, compositions, and devices
IL241355B (en) Pyrazole-amide compounds, preparations containing them and their uses
DK3027701T3 (en) Compositions comprising 1,1-difluoroethene (r-1132a)
HK1210806A1 (en) Method for manufacturing immunocyte-containing composition, and cancer-treating composition
EP3006525A4 (en) ASPHALT-URETHANE COMPOSITION
HK1213735A1 (zh) 用於增强授粉的組合物及其製備方法
GB201319540D0 (en) Composition
GB201318489D0 (en) Composition
GB201317388D0 (en) Composition
EP3066178A4 (en) GREASE COMPOSITION
GB201322456D0 (en) Radiotracer compositions and methods
GB201319538D0 (en) Composition
GB201306984D0 (en) Composition
GB201317196D0 (en) Composition
GB201307622D0 (en) Composition
HK1214131A1 (zh) 包含氫化可的松的組合物
ZA201505650B (en) New compositions
GB201320504D0 (en) Composition
GB201308502D0 (en) Composition
GB201301774D0 (en) Composition
GB201318394D0 (en) Composition